Iżrael - Ebrajk - Ministry of Health

cortex dental implants industries ltd. - רופא שיניים - the cortex dental implants system is indicated for use in surgical and restorative applications for placement in the maxillary and/or mandibular arches to provide support for prosthetic restorations in edentulous or partially edentulous patients. the cortex implants are for single-stage or two-stage surgery.

Iżrael - Ebrajk - Ministry of Health

dentack implants ltd. - רופא שיניים - מיועד לפרוצדורות השתלות שיניים ופרוצדורות דנטליות שונות לפי שיקול רופא השיניים

Iżrael - Ebrajk - Ministry of Health

inovamed ltd - bicalutamide - טבליות מצופות פילם - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0), bicalutamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable

Iżrael - Ebrajk - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. reflux esophagitis:- treatment ; - long-term management; - maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux oesophagitis in children from one year of age and older. - maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. - zollinger-ellison syndrome. - treatment and prevention of nsaid - associated duodenal and gastric ulcers or erosions in high risk patients.

Iżrael - Ebrajk - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Iżrael - Ebrajk - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 40 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year.helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Iżrael - Ebrajk - Ministry of Health

dexcel ltd, israel - omeprazole - קפליות - omeprazole 10 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

Iżrael - Ebrajk - Ministry of Health

given imaging ltd - רופא - the pillcam platform with a pillcam sb capsule is intended for visualization of the small bowel mucosa including assessment for severity and extent of small bowel abnormalities. it may be used as a tool in the detection, diagnosis and surveillance of abnormalities and conditions of the small bowel such as: • inflammatory bowel diseases including crohn’s disease, colitis, indeterminate colitis and ileitis • obscure bleeding (ogib) and iron deficiency anemia (ida) • tumors of the small bowel including benign and malignant types and polyposis syndromes (fap and pjs) • malabsorption abnormalities including celiac disease and motility issues relating to ibs it may be used in the detection of small bowel mucosal damage as defined in the capsule endoscopy standardized terminology (cest) to include: • excavated lesions such as ulcers, aphtha ulcers, erosions, scars and diverticulum • erythematous mucosa • edematous mucosa • flat lesions such as red spots, plaque, angioectasia • protruding lesions such as nodules, pol

Iżrael - Ebrajk - Ministry of Health

teva medical marketing ltd. - ascorbic acid; biotin; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; phytomenadione; pyridoxine (vit b6) hydrochloride; riboflavine; thiamine (vit b1) hydrochloride; tocopherol (vit e) (as tocopheryl acetate); vitamin a palmitate - תוסף לתמיסה לאינפוזיה - ascorbic acid 80 mg / 4 ml; vitamin a palmitate 2300 iu / 4 ml; colecalciferol 400 iu / 4 ml; thiamine (vit b1) hydrochloride 1.2 mg / 4 ml; riboflavine 1.4 mg / 4 ml; nicotinamide 17 mg / 4 ml; pyridoxine (vit b6) hydrochloride 1 mg / 4 ml; dexpanthenol 5 mg / 4 ml; tocopherol (vit e) (as tocopheryl acetate) 7 iu / 4 ml; phytomenadione 0.2 mg / 4 ml; folic acid 140 mcg/ml; biotin 20 mcg/ml; cyanocobalamin 1 mcg/ml - multivitamins and other minerals, incl. combinations - multivitamins and other minerals, incl. combinations - for use as a multiple vitamin supplement for infants and children up to 11 years of age. it is also indicated in other situations where there are increased requirements for vitamins due to stress situations such as surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. the use of a multivitamin product obviates the need to speculate on the status of individual vitamin nutriture.

Iżrael - Ebrajk - Ministry of Health

sanofi israel ltd - agalsidase beta - אבקה להכנת תמיסה מרוכזת לעירוי - agalsidase beta 35 mg/vial - agalsidase beta - agalsidase beta - fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease. (alfa - galactosidase a deficiency).